Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD
NCT: NCT04676854 · ACTIVE_NOT_RECRUITING
Brief Summary
The objective of this study is to evaluate the efficacy and safety of the PRIMA System in patients with atrophic AMD. Eligible subjects will be implanted with the PRIMA Implant. The subjects will be assessed with various visual function and functional vision tests at defined timepoints throughout the clinical investigation with the PRIMA System (Implant and Visual Processor).
Frequently Asked Questions
What is Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD?
Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD is a clinical trial registered under NCT04676854. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04676854?
The current status of NCT04676854 (Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD) is: ACTIVE_NOT_RECRUITING.
When did Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD start?
Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD started on 2020-11-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.